All locations

See a listing of all our Children’s Hospital Colorado locations including inpatient, outpatient, therapy, surgery facilities and more.

Locations near you

See all locations

Mark Abzug, MD

Provider's Specialties

Infectious Disease - Pediatric
Pediatrics

Provider's location(s)

Anschutz Medical Campus, Aurora

View map

Patient ratings

Patient ratings and reviews are not available

Why?

Pediatric Infectious Disease Program

(720)777-6981

Insurance plans accepted

We participate with most major health insurance plans and national transplant networks.

View the full list

Prepare for your visit

We want to make sure you know what to expect before you arrive.

See the checklist

Get to know Mark Abzug, MD

Departments and Programs

Infectious Disease

Conditions Treated

Viral Infections
AIDS
AIDS / HIV Disease
AIDS Immunization

Languages spoken

English

Experience and background

I am interested in Perinatal Infection, Enterovirus Infections and Infections in Immunocompromised Patients.

Medical Education 1982

Boston University School of Medicine

Internship 1983

Strong Memorial Hospital of the University of Rochester Program

Residency 1985

Strong Memorial Hospital of the University of Rochester Program

Fellowship 1988

University of Colorado (University Hospital) Program

For Patients:
Dr. Abzug directs clinical research on patients with viral infections, infections in immunocompromised patients, and pediatric HIV infection. He is involved in national collaborative clinical trials of antiviral therapies, including studies of the National Institutes of Health Collaborative Antiviral Study Group and the National Institutes of Health International Maternal Pediatric Adolescent AIDS Clinical Trials Network.

For Referring Providers:
Dr. Abzug directs clinical research on patients with viral infections, infections in immunocompromised patients, and pediatric HIV infection. He is involved in national collaborative clinical trials of antiviral therapies, including studies of the National Institutes of Health Collaborative Antiviral Study Group and the National Institutes of Health International Maternal Pediatric Adolescent AIDS Clinical Trials Network.